DETECTION OF P53 MUTATIONS BY SINGLE-STRAND CONFORMATION POLYMORPHISMS (SSCP) GEL-ELECTROPHORESIS - A COMPARATIVE-STUDY OF RADIOACTIVE AND NONRADIOACTIVE SILVER-STAINED SSCP ANALYSIS
S. Bosari et al., DETECTION OF P53 MUTATIONS BY SINGLE-STRAND CONFORMATION POLYMORPHISMS (SSCP) GEL-ELECTROPHORESIS - A COMPARATIVE-STUDY OF RADIOACTIVE AND NONRADIOACTIVE SILVER-STAINED SSCP ANALYSIS, Diagnostic molecular pathology, 4(4), 1995, pp. 249-255
p53 mutations are the most common genetic abnormality in human tumors,
but their clinical significance remains to be precisely elucidated. C
onventional single-strand conformation polymorphism (SSCP) analysis, a
well-established technique for detecting p53 mutations, uses radioact
ively labeled polymerase chain reaction (PCR) products, which migrate
abnormally in the presence of mutations. We performed radioactive PCR-
SSCP analysis in a series of 30 formalin-fixed, paraffin-embedded ovar
ian carcinomas and two cell lines (SW480 and Caov4) harboring known ho
mozygous p53 mutations and compared the results with nonradioactive si
lver-stained SSCP. The purpose was to assess whether nonradioactive SS
CP is suitable for detecting p53 mutations in a rapid, sensitive, cost
-effective fashion, without the need of radioactive isotopes. We accom
plished PCR amplification of p53 exons 5 through 8 in 26 carcinomas, a
nd radioactive SSCP detected p53 mutations in 13 tumors: three mutatio
ns were localized in exon 5, six in exon 6, two in exon 7, and two in
exon 8. All mutations were correctly identified with nonradioactive SS
CP, except for one exon 8 mutation. To establish the sensitivity of no
nradioactive SSCP, DNA samples of SW480 and Caov4 were mixed with incr
easing amounts (0-90%) of normal DNA and subjected to PCR-SSCP analysi
s. Mutations were detected until the concentration of SW480 and Caov4
was 15% and 10%, respectively, of the total sample, The results of our
investigation demonstrate that nonradioactive silver-stained SSCP is
a sensitive, rapid, and Simple technique to detect p53 mutations, even
in formalin-fixed tissues, and could be easily used to investigate la
rge series of patients to assess the clinical significance of p53 muta
tions in human tumors.